1,721,155 research outputs found

    Clinico-pathologic, histophenotypic, molecular and prognostic characterization of small bowel carcinomas associated with celiac disease or Chron’s disease.

    Full text link
    Non-familial small bowel carcinomas are relatively rare and have a poor prognosis. Celiac disease and Crohn’s disease are predisposing conditions for small bowel carcinoma development. In this study, small bowel carcinomas associated with celiac disease (n=26), small bowel carcinomas associated with Crohn’s disease (n=25) and sporadic small bowel carcinomas (n=25) were systematically compared. We found that in patients undergoing surgery for small bowel carcinomas the underlying immune-mediated disorder represents a stage-independent prognostic factor. Despite their common origin in a chronically inflamed mucosa, celiac disease-associated and Crohn’s disease-associated small bowel carcinomas differ substantially in tumor cell phenotype, tumor-infiltrating lymphocyte density, microsatellite instability status, Wnt pathway activation, as well as mucosal precursor lesions. Moreover, Epstein-Barr virus-positive carcinomas may occur in the ileum of Crohn’s disease patients and are characterised by increased tumor-infiltrating lymphocytes, either with lymphoepithelioma-like or with a more conventional glandular histology

    Histogenesis and natural history of gut neuroendocrine tumors: present status

    No full text
    Important progress has been made during the last decade in the histopathologic characterization and overall prognostic evaluation of gut neuroendocrine tumors. However, some issues like tumor histogenesis, typing, functional characterization, and preferred site of origin deserve further clarification. This is a survey of the present status of the matter outlining some of the open points. In particular, careful comparison of normal gut endocrine cell types with related endocrine tumors so far identified shows an unexplained lack of neoplasms involving upper small intestine cells like secretin, cholecystokinin, motilin, and GIP cells, as well as the equally unexplained concentration of serotonin EC cell tumors in the ileum and appendix or of somatostatin cell tumors in the duodenal papillary region, despite their wide distribution in the normal gut, not to mention gastrinomas arising in the pancreas, normally devoid of gastrin cells. Special functional (e.g., achlorhydria-driven hypergastrinemia) or pathologic (as chronic inflammation) conditions may locally influence the proliferative and differentiation state of the endocrine cells thus promoting tumor growth. Tumor histologic structure, differentiation level, and proliferative index as well as gastrointestinal wall barriers to tumor diffusion may account for most prognostic parameters, with considerable changes, however, according to the tumor type and site. Thus, further work is needed to develop tumor- and site-adjusted prognostic parameters
    corecore